M
Mizuho Latest Price Targets & Analyst Ratings
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
501 |
501
Avista
AVA
$2.99B
|
AC
Anthony Crowdell
| $36.87 | $36 |
2%
downside
| Neutral | 1 year ago |
|
502 |
502
PPL Corp
PPL
$26.6B
|
AC
Anthony Crowdell
| $35.96 | $28 |
22%
downside
| Neutral | 1 year ago |
|
503 |
503
GE HealthCare
GEHC
$34.6B
|
AP
Anthony Petrone
| $75.73 | $105 |
39%
upside
| Buy | 1 year ago |
|
504 |
504
Ashland
ASH
$2.51B
|
JR
John Roberts
| $54.91 | $110 |
100%
upside
| Buy | 1 year ago |
|
505 |
505
Encompass Health
EHC
$12.6B
|
AH
Ann Hynes
| $125.58 | $95 |
24%
downside
| Buy | 1 year ago |
|
506 |
506
Enliven Therapeutics
ELVN
$1.19B
|
SS
Salim Syed
| $20.15 | $34 |
69%
upside
| Buy | 1 year ago |
|
507 |
507
Inspire Medical Systems
INSP
$2.56B
|
AP
Anthony Petrone
| $86.46 | $250 |
189%
upside
| Buy | 1 year ago |
|
508 |
508
Evolus
EOLS
$495M
|
UE
Uy Ear
| $7.66 | $23 |
200%
upside
| Buy | 1 year ago |
|
509 |
509
Cigna
CI
$81.5B
|
AH
Ann Hynes
| $305.31 | $385 |
26%
upside
| Buy | 1 year ago |
|
510 |
510
CRISPR Therapeutics
CRSP
$4.99B
|
SS
Salim Syed
| $54.86 | $99 |
80%
upside
| Buy | 1 year ago |
|
511 |
511
Universal Health Services
UHS
$12.1B
|
AH
Ann Hynes
| $190.12 | $200 |
5%
upside
| Buy | 1 year ago |
|
512 |
512
Pinnacle West Capital
PNW
$10.6B
|
AC
Anthony Crowdell
| $89 | $75 |
16%
downside
| Buy | 1 year ago |
|
513 |
513
BridgeBio Pharma
BBIO
$10.2B
|
SS
Salim Syed
| $53.38 | $53 |
1%
downside
| Buy | 1 year ago |
|
514 |
514
Sabre
SABR
$675M
|
MB
Matthew Brooks
| $1.71 | $3 |
75%
upside
| Neutral | 1 year ago |
|
515 |
515
MiMedx Group
MDXG
$1.06B
|
AP
Anthony Petrone
| $7.14 | $14 |
96%
upside
| Buy | 1 year ago |
|
516 |
516
iQIYI
IQ
$2.61B
|
AH
Ann Hynes
| $2.71 | $268 |
9,789%
upside
| Buy | 1 year ago |
|
517 |
517
Brixmor Property Group
BRX
$8.63B
|
VM
Vikram Malhotra
| $28.20 | $24 |
15%
downside
| Neutral | 1 year ago |
|
518 |
518
Palo Alto Networks
PANW
$130B
|
GM
Gregg Moskowitz
| $194.46 | $175 |
10%
downside
| Buy | 1 year ago |
|
519 |
519
International Flavors & Fragrances
IFF
$16.9B
|
CP
Christopher Parkinson
| $66.03 | $82 |
24%
upside
| Neutral | 1 year ago |
|
520 |
520
Element Solutions
ESI
$6.33B
|
KDB
Kieran De Brun
| $26.21 | $26 |
1%
downside
| Buy | 1 year ago |
|
521 |
521
McKesson
MCK
$85.5B
|
AH
Ann Hynes
| $687.40 | $505 |
27%
downside
| Neutral | 1 year ago |
|
522 |
522
Uber
UBER
$190B
|
JL
James Lee
| $90.99 | $83 |
9%
downside
| Buy | 1 year ago |
|
523 |
523
Neurocrine Biosciences
NBIX
$14.3B
|
UE
Uy Ear
| $144.10 | $140 |
3%
downside
| Neutral | 1 year ago |
|
524 |
524
Cencora
COR
$56.7B
|
OO
Omotayo Okusanya
| $292.50 | $224 |
23%
downside
| Neutral | 1 year ago |
|
525 |
525
Corteva
CTVA
$49.1B
|
CP
Chris Parkinson
| $72.30 | $56 |
23%
downside
| Buy | 1 year ago |
|